Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic power assessment of clinical parameters to predict neoadjuvant response therapy in HER2-positive breast cancer patients: A machine learning approach.
Fanizzi A, Latorre A, Bavaro DA, Bove S, Comes MC, Di Benedetto EF, Fadda F, La Forgia D, Giotta F, Palmiotti G, Petruzzellis N, Rinaldi L, Rizzo A, Lorusso V, Massafra R. Fanizzi A, et al. Among authors: rinaldi l. Cancer Med. 2023 Nov;12(22):20663-20669. doi: 10.1002/cam4.6512. Epub 2023 Oct 31. Cancer Med. 2023. PMID: 37905688 Free PMC article.
A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results.
Massafra R, Latorre A, Fanizzi A, Bellotti R, Didonna V, Giotta F, La Forgia D, Nardone A, Pastena M, Ressa CM, Rinaldi L, Russo AOM, Tamborra P, Tangaro S, Zito A, Lorusso V. Massafra R, et al. Among authors: rinaldi l. Front Oncol. 2021 Mar 11;11:576007. doi: 10.3389/fonc.2021.576007. eCollection 2021. Front Oncol. 2021. PMID: 33777733 Free PMC article.
A ultrasound-based radiomic approach to predict the nodal status in clinically negative breast cancer patients.
Bove S, Comes MC, Lorusso V, Cristofaro C, Didonna V, Gatta G, Giotta F, La Forgia D, Latorre A, Pastena MI, Petruzzellis N, Pomarico D, Rinaldi L, Tamborra P, Zito A, Fanizzi A, Massafra R. Bove S, et al. Among authors: rinaldi l. Sci Rep. 2022 May 12;12(1):7914. doi: 10.1038/s41598-022-11876-4. Sci Rep. 2022. PMID: 35552476 Free PMC article.
An Invasive Disease Event-Free Survival Analysis to Investigate Ki67 Role with Respect to Breast Cancer Patients' Age: A Retrospective Cohort Study.
Massafra R, Bove S, La Forgia D, Comes MC, Didonna V, Gatta G, Giotta F, Latorre A, Nardone A, Palmiotti G, Quaresmini D, Rinaldi L, Tamborra P, Zito A, Rizzo A, Fanizzi A, Lorusso V. Massafra R, et al. Among authors: rinaldi l. Cancers (Basel). 2022 Apr 28;14(9):2215. doi: 10.3390/cancers14092215. Cancers (Basel). 2022. PMID: 35565344 Free PMC article.
Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer.
Rizzo A, Massafra R, Fanizzi A, Rinaldi L, Cusmai A, Latorre A, Zaccaria GM, Ronchi M, Telegrafo M, Gadaleta-Caldarola G, Giotta F, Lorusso V, Palmiotti G. Rizzo A, et al. Among authors: rinaldi l. Expert Opin Investig Drugs. 2022 Jul;31(7):707-713. doi: 10.1080/13543784.2022.2078191. Epub 2022 May 18. Expert Opin Investig Drugs. 2022. PMID: 35575038
1,182 results